cti-mcp

Enables to analyze Korean pharma/biotech stocks using clinical trial data from ClinicalTrials.gov and market data from Naver Finance, providing 100-point scoring, decision labels, and technical indicators.

→ hjsh200219/trading-by-clinical-trial · listed on glama

Is this your MCP?

Claim it to get a verified publisher badge, a free copy of our full audit findings, and direct contact for any high-priority issues we find.

Install from

Glama

M8ven verifies MCPs across every public registry — install directly from whichever one you prefer.

// key findings

✅

No credential exfiltration, no sensitive file access, no obfuscation

Static analysis found nothing flowing your secrets to unexpected places.

// full audit trail

The full breakdown of what we checked, the deductions that landed, the network hosts, the dependency advisories, and concrete fix guidance is available to verified publishers.

// improvement guidance — verified publishers only

We have 6 concrete improvements we can share with the publisher of this MCP. Each comes with specific guidance to raise the trust score.

// embed badge in your README

[![M8ven Score](https://m8ven.ai/badge/mcp/hjsh200219-trading-by-clinical-trial-qvgmaq)](https://m8ven.ai/mcp/hjsh200219-trading-by-clinical-trial-qvgmaq)

commit: 00890f81960a5d2d5da09b987a302dc6cdfeda0c

code hash: b84bae17c9a0297f1608455becebbd5b8c3b1f553c19a519d3fe39f35b2b1916

verified: 6/22/2026, 12:13:14 PM

view raw JSON →